Published in Tissue Eng Part C Methods on June 29, 2011
Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer. J Vis Exp (2015) 0.88
Recent advances in bioprinting and applications for biosensing. Biosensors (Basel) (2014) 0.87
Printing cancer cells into intact microvascular networks: a model for investigating cancer cell dynamics during angiogenesis. Integr Biol (Camb) (2015) 0.81
Connections matter: channeled hydrogels to improve vascularization. Front Bioeng Biotechnol (2014) 0.79
Laser Direct-Write Onto Live Tissues: A Novel Model for Studying Cancer Cell Migration. J Cell Physiol (2016) 0.77
Single-step laser-based fabrication and patterning of cell-encapsulated alginate microbeads. Biofabrication (2013) 0.76
Vascularization of three-dimensional engineered tissues for regenerative medicine applications. Acta Biomater (2016) 0.76
Tissue-Mimicking Geometrical Constraints Stimulate Tissue-Like Constitution and Activity of Mouse Neonatal and Human-Induced Pluripotent Stem Cell-Derived Cardiac Myocytes. J Funct Biomater (2016) 0.75
Additive Manufacturing of Biomedical Constructs with Biomimetic Structural Organizations. Materials (Basel) (2016) 0.75
Cells on chips. Nature (2006) 8.40
Hydrogels for tissue engineering. Chem Rev (2001) 7.25
Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development (1999) 7.12
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol (2004) 5.51
An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35
Cell interactions with three-dimensional matrices. Curr Opin Cell Biol (2002) 4.34
Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods (2006) 3.20
The use and analysis of microarray data. Nat Rev Drug Discov (2002) 3.08
Organ printing: tissue spheroids as building blocks. Biomaterials (2009) 2.43
Inkjet printing of viable mammalian cells. Biomaterials (2005) 2.04
Exploring the regulation of human neural precursor cell differentiation using arrays of signaling microenvironments. Mol Syst Biol (2006) 1.90
Influence of seeding density and dynamic deformational loading on the developing structure/function relationships of chondrocyte-seeded agarose hydrogels. Ann Biomed Eng (2002) 1.83
Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials (2005) 1.78
High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol (2009) 1.56
Engineering cellular microenvironments to improve cell-based drug testing. Drug Discov Today (2002) 1.54
Biocompatible inkjet printing technique for designed seeding of individual living cells. Tissue Eng (2006) 1.50
Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng (2007) 1.42
The regulation of stem cell differentiation by cell-cell contact on micropatterned material surfaces. Biomaterials (2009) 1.36
Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog (2009) 1.36
Delivery of human fibroblast cells by piezoelectric drop-on-demand inkjet printing. Biomaterials (2007) 1.28
Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation. Tissue Eng Part A (2010) 1.24
Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF? J Cell Biochem (2000) 1.23
Laser assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials (2010) 1.21
Jet-based methods to print living cells. Biotechnol J (2006) 1.21
Cell and organ printing 1: protein and cell printers. Anat Rec A Discov Mol Cell Evol Biol (2003) 1.13
Living-cell microarrays. Annu Rev Biomed Eng (2009) 1.12
In vitro chondrogenic differentiation of human mesenchymal stem cells in collagen microspheres: influence of cell seeding density and collagen concentration. Biomaterials (2008) 1.12
A cultural renaissance: in vitro cell biology embraces three-dimensional context. Exp Neurol (2005) 1.07
Laser printing of single cells: statistical analysis, cell viability, and stress. Ann Biomed Eng (2005) 1.06
An adaptable hydrogel array format for 3-dimensional cell culture and analysis. Biomaterials (2008) 1.05
Laser-guided assembly of heterotypic three-dimensional living cell microarrays. Biophys J (2006) 1.05
Formation of human capillaries in vitro: the engineering of prevascularized matrices. Tissue Eng Part A (2010) 1.05
Direct cell writing of 3D microorgan for in vitro pharmacokinetic model. Tissue Eng Part C Methods (2008) 1.03
Laser-based direct-write techniques for cell printing. Biofabrication (2010) 1.02
Survival and proliferative ability of various living cell types after laser-induced forward transfer. Tissue Eng (2006) 1.02
Laser printing of stem cells for biofabrication of scaffold-free autologous grafts. Tissue Eng Part C Methods (2010) 0.99
Laser printing of skin cells and human stem cells. Tissue Eng Part C Methods (2010) 0.99
Cultivating liver cells on printed arrays of hepatocyte growth factor. Biomaterials (2009) 0.96
Printing of protein microarrays via a capillary-free fluid jetting mechanism. Proteomics (2005) 0.93
Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials (2003) 0.92
Adult human bone marrow- and adipose tissue-derived stromal cells support the formation of prevascular-like structures from endothelial cells in vitro. Tissue Eng Part A (2010) 0.90
Reduced thrombocyte adhesion to endothelialized poly 4-methyl-1-pentene gas exchange membranes—a first step toward bioartificial lung development. Tissue Eng Part A (2010) 0.90
Adipogenic differentiation of laser-printed 3D tissue grafts consisting of human adipose-derived stem cells. Biofabrication (2011) 0.88
The maintenance of pluripotency following laser direct-write of mouse embryonic stem cells. Biomaterials (2010) 0.85
Three-dimensional cell growth on structures fabricated from ORMOCER by two-photon polymerization technique. J Biomater Appl (2007) 0.85
Endothelial cell activation in a VEGF-A gradient: relevance to cell fate decisions. Microvasc Res (2010) 0.84
Dispensing pico to nanolitre of a natural hydrogel by laser-assisted bioprinting. Biomed Eng Online (2011) 0.81
Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels. Tissue Eng Part A (2011) 0.79
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation (2007) 6.41
The safety of moderate hypothermic lower body circulatory arrest with selective cerebral perfusion: a propensity score analysis. J Thorac Cardiovasc Surg (2007) 3.08
Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med (2012) 2.86
Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell (2009) 2.78
Cryopreserved human allografts (homografts) for the management of graft infections in the ascending aortic position extending to the arch. Eur J Cardiothorac Surg (2012) 2.70
Development of a composite degradable/nondegradable tissue-engineered vascular graft. Artif Organs (2008) 2.16
Long-term results after aortic valve-sparing operation (David I). Eur J Cardiothorac Surg (2012) 2.16
Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg (2003) 2.14
Total aortic arch replacement with a novel four-branched frozen elephant trunk graft: first-in-man results. Eur J Cardiothorac Surg (2012) 2.11
Acute treatment of ST-segment-elevation myocardial infarction: is there a role for the cardiac surgeon? Ann Thorac Surg (2009) 2.11
The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06
Long-term cardiac allograft valves after heart transplant are functionally and structurally preserved, in contrast to homografts and bioprostheses. J Heart Valve Dis (2006) 2.04
Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv (2006) 1.97
TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat (2006) 1.93
Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med (2011) 1.84
Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg (2011) 1.81
Ascending aortic cannulation in acute aortic dissection type A: the Hannover experience. Eur J Cardiothorac Surg (2008) 1.80
Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant (2010) 1.78
Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail (2010) 1.75
Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet (2012) 1.75
Elephant trunk procedure 27 years after Borst: what remains and what is new? Eur J Cardiothorac Surg (2011) 1.73
Ascending aortic cannulation for Stanford type A acute aortic dissection: another option. J Thorac Cardiovasc Surg (2003) 1.73
Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis (2009) 1.70
Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol (2003) 1.69
Total aortic arch replacement with the frozen elephant trunk technique: 10-year follow-up single-centre experience. Eur J Cardiothorac Surg (2013) 1.61
Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect. Ann Thorac Surg (2006) 1.61
Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg (2006) 1.59
Cardiac retransplantation: is it justified in times of critical donor organ shortage? Long-term single-center experience. Eur J Cardiothorac Surg (2008) 1.54
Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass. Eur J Cardiothorac Surg (2005) 1.54
Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol (2007) 1.53
Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm. J Heart Lung Transplant (2013) 1.53
Predictors of aneurysmal formation after surgical correction of aortic coarctation. J Am Coll Cardiol (2002) 1.51
Sutureless perceval aortic valve replacement: results of two European centers. Ann Thorac Surg (2012) 1.51
Pulmonary preservation with LPD and celsior solution in porcine lung transplantation after 24 h of cold ischemia. Eur J Cardiothorac Surg (2004) 1.51
Isolated surgical aortic valve replacement after previous coronary artery bypass grafting with patent grafts: is this old-fashioned technique obsolete? Eur J Cardiothorac Surg (2008) 1.51
The impact of deep and moderate body temperatures on end-organ function during hypothermic circulatory arrest. Eur J Cardiothorac Surg (2011) 1.51
Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg (2002) 1.49
Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium. Eur Heart J (2012) 1.49
Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg (2002) 1.49
C1-esterase-inhibitor for primary graft dysfunction in lung transplantation. Transplantation (2014) 1.49
Total aortic arch replacement with the elephant trunk technique: single-centre 30-year results. Eur J Cardiothorac Surg (2013) 1.48
Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc (2011) 1.46
Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters. Proc Natl Acad Sci U S A (2013) 1.46
Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg (2008) 1.46
A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support. Eur J Cardiothorac Surg (2012) 1.46
Hypothermic circulatory arrest with moderate, deep or profound hypothermic selective antegrade cerebral perfusion: which temperature provides best brain protection? Eur J Cardiothorac Surg (2006) 1.44
Microbial adhesion on membrane oxygenators in patients requiring extracorporeal life support detected by a universal rDNA PCR test. ASAIO J (2013) 1.44
Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. Europace (2010) 1.43
Myocardial tissue engineering: the extracellular matrix. Eur J Cardiothorac Surg (2008) 1.43
One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg (2012) 1.43
Economic aspects of deep sternal wound infections. Eur J Cardiothorac Surg (2009) 1.42
The frozen elephant trunk technique: a new treatment for thoracic aortic aneurysms. J Thorac Cardiovasc Surg (2003) 1.42
Prevalence of CCR5Delta32 polymorphism in long-term survivors of heart transplantation. Transpl Immunol (2006) 1.42
Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study. Crit Care Med (2008) 1.42
Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction. Transplantation (2015) 1.41
Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg (2009) 1.41
Allogeneic CD4+CD25high T cells regulate obliterative bronchiolitis of heterotopic bronchus allografts in both porcinized and humanized mouse models. Transplantation (2015) 1.40
No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation (2006) 1.39
Clinical relevance of intracranial high intensity transient signals in patients following prosthetic aortic valve replacement. Eur J Cardiothorac Surg (2002) 1.38
Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Crit Care Med (2007) 1.35
Hypothermic circulatory arrest with selective antegrade cerebral perfusion in ascending aortic and aortic arch surgery: a risk factor analysis for adverse outcome in 501 patients. J Thorac Cardiovasc Surg (2008) 1.35
Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg (2006) 1.33
Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol (2006) 1.31
Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation (2003) 1.30
Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J (2011) 1.29
Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbecks Arch Surg (2011) 1.26
Aortic valve replacement in geriatric patients with small aortic roots: are sutureless valves the future? Interact Cardiovasc Thorac Surg (2013) 1.25
Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant (2005) 1.25
Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: upper hemisternotomy combined with anterolateral thoracotomy. J Thorac Cardiovasc Surg (2011) 1.25
Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol (2011) 1.23
Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun (2005) 1.22
Nonadherence with diet and fluid restrictions among adults having hemodialysis. J Nurs Scholarsh (2005) 1.22
Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care (2011) 1.21
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg (2008) 1.21
Graphene synthesis on cubic SiC/Si wafers. perspectives for mass production of graphene-based electronic devices. Nano Lett (2010) 1.21
Safety of the use of Tissucol Duo S in cardiovascular surgery: retrospective analysis of 2149 patients after coronary artery bypass grafting. Eur J Cardiothorac Surg (2007) 1.20
Evolving strategies for treatment of acute aortic dissection type A. Circulation (2004) 1.20
Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg (2002) 1.19
Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One (2012) 1.18
The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials (2007) 1.18
Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J (2012) 1.16
Aortic valve reimplantation in ascending aortic aneurysm: risk factors for early valve failure. Ann Thorac Surg (2002) 1.15
Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant (2012) 1.15
Aortic root surgery in Marfan syndrome: Comparison of aortic valve-sparing reimplantation versus composite grafting. J Thorac Cardiovasc Surg (2004) 1.14
Technical innovations of carinal resection for nonsmall-cell lung cancer. Ann Thorac Surg (2006) 1.14
Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome. Hum Mutat (2005) 1.14
Decade of aortic valve sparing reimplantation: are we pushing the limits too far? Circulation (2005) 1.13
Increase in left ventricular assist device thrombosis. N Engl J Med (2014) 1.13
Tissue engineered skin substitutes created by laser-assisted bioprinting form skin-like structures in the dorsal skin fold chamber in mice. PLoS One (2013) 1.12
Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation (2011) 1.12
Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods (2012) 1.11
Sternal microcirculation after skeletonized versus pedicled harvesting of the internal thoracic artery: a randomized study. J Thorac Cardiovasc Surg (2008) 1.10
Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials (2010) 1.09
Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation (2006) 1.09
Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms. J Vasc Surg (2011) 1.09